Venue: Committee Room - Bootle Town Hall, Trinity Road, Bootle, L20 7AE. View directions
Contact: Amy Dyson Democratic Services Officer
No. | Item | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apologies for Absence Minutes: An apology for absence was received from Deborah Butcher (Sefton Council).
|
|||||||||||||||||
Minutes of Previous Meeting PDF 230 KB Minutes of the meeting held on 6 December 2023 Minutes: RESOLVED:
That subject to the following addition in the list of those present, the Minutes of the meeting held on 6 December 2023 be confirmed as a correct record:
· Angela White, present remotely, via Teams
|
|||||||||||||||||
Declarations of Interest Members are requested at a meeting where a disclosable pecuniary interest or personal interest arises, which is not already included in their Register of Members' Interests, todeclare any interests that relate to an item on the agenda.
Where a Member discloses a Disclosable Pecuniary Interest, he/she must withdraw from the meeting room, including from the public gallery, during the whole consideration of any item of business in which he/she has an interest, except where he/she is permitted to remain as a result of a grant of a dispensation.
Where a Member discloses a personal interest he/she must seek advice from the Monitoring Officer or staff member representing the Monitoring Officer to determine whether the Member should withdraw from the meeting room, including from the public gallery, during the whole consideration of any item of business in which he/she has an interest or whether the Member can remain in the meeting or remain in the meeting and vote on the relevant decision. Minutes: No declarations of any disclosable pecuniary interests or personal interests were received. |
|||||||||||||||||
Presentation of the Associate Director of Partnerships and Sustainability, NHS Cheshire and Merseyside Additional documents: Minutes: The Board received a presentation of the Associate Director of Partnerships and Sustainability, NHS Cheshire and Merseyside which recommended that the Board formally adopt the Anchor Cheshire and Merseyside Anchor Institution Charter and Principles.
‘Anchor institutions’ were usually large public sector organisations rooted in and connected to their local communities. They could improve health through their influence on local social and economic conditions by adapting the way they employed people, purchased goods and services, used buildings and spaces, reduced environmental impact, and worked in partnership.
The Board discussed the benefits of adopting the Anchor Charter.
RESOLVED:
That the Anchor Cheshire and Merseyside Anchor Institution Charter and Principles be formally adopted.
|
|||||||||||||||||
Merseyside and IoM CDOP Annual Report 2022-23 PDF 270 KB Report of the Chair of the Merseyside and Isle of Man Child Death Overview Panel Additional documents: Minutes: The Board received the report of the Independent Chair of Merseyside and Isle of Man Child Death Overview Panel. The report outlined the processes adopted by Merseyside and Isle of Man CDOP, assured the Board of the effective inter-agency system for reviewing child deaths across Merseyside and the Isle of Man which was in line with national guidance. The report provided an overview of information on trends and patterns in child deaths reviewed across Merseyside and the Isle of Man during 2022-23 and highlighted issues arising from those reviewed child deaths, – for the region as a whole as well as identifying pertinent issues in each Local Authority area. It also reported on progress from the issues identified in Merseyside and Isle of Man CDOP’s last annual report.
The Board discussed the governance structure and the opportunity for more joint working opportunities.
RESOLVED: That
|
|||||||||||||||||
Pharmaceutical Needs Assessment 2025-28 Development Process and Scope Report PDF 405 KB Report of the Director of Public Health Minutes: The Board considered the report of the Director of Public Health which outlined the resources and processes required to deliver a fully revised three-year Sefton Pharmaceutical Needs Assessment (PNA) for 1 October 2025. The report provided the Health and Wellbeing Board with relevant information about:
· Legal context · Uses of the PNA · The range of information required · Required and recommended steps and process · Timescales · Resource implications and collaboration
The Board discussed its statutory responsibilities and the role of pharmacies as an important local community resource.
RESOLVED: That
|
|||||||||||||||||
Progress Update on the Sefton Child Poverty Strategy PDF 2 MB Report of the Director of Public Health Minutes: The Board considered the report of the Director of Public Health which provided an update on the progress of the Sefton Child Poverty Strategy by providing the following:
· A summary of strategy background and development · A brief overview of the child poverty strategy’s goals, priorities, and suggested actions · Discussion on arrangements for implementation, governance, and monitoring · A review of progress using the accountability framework · Comments on wider policy context – opportunities and challenges
The Board discussed Sefton’s priorities and encouraged engagement with relevant partners.
RESOLVED: That
|
|||||||||||||||||
Report of the Director of Public Health Additional documents:
Minutes: The Board considered the report of the Director of Public Health which presented the Board with a summary of activity from the five identified subgroups and sought approval for the Better Care Fund 2023-25 Quarter 3 Quarterly Reporting Template. The report also included a summary of activity from the Combatting Drugs Partnership and outlined changes to pharmacies in Sefton. The report outlined activity since the last update received by the Board on 6 December 2023, namely:
The Board also received an update from the Combatting Drugs Partnership (CDP) which had met once since the last update, on 13 December 2023. The meeting had a themed spotlight on Young People. The Partnership received updates from the CDP subgroups.
The Board was required to receive and note changes to Pharmacies in its area from NHS England, the Board received three notifications from September 2023 to the date of the meeting.
RESOLVED: That
|